Q Therapeutics Inc., Salt Lake City, has appointed Tom Parks as an independent member of the company’s board of directors. Parks also has agreed to serve on the board's Nominating and Governance Committee. Parks has more than 30 years of experience in life science research and its translation into therapeutic products. He began work as a faculty member in the Department of Neurobiology & Anatomy at the University of Utah School of Medicine in 1978, including serving as chair of the department from 1992-2007. He was a co-founder of NPS Pharmaceuticals Inc. and served on its board from 1986-2006. From 2008-2016, Parks was vice president for research and president of the Research Foundation for the University of Utah. He currently serves on the boards of Navigen Pharmaceuticals Inc., SentrX Animal Care Inc. and ConusRx Inc.